Results 191 to 200 of about 297,477 (238)

Baclofen Potentiates Neurological Impairment in Dialysis Disequilibrium Syndrome. [PDF]

Cureus
Guo J, Salam L, Blackman K, Brown C.
europepmc   +1 more source

Fatigue and Related Sleep Disturbances in Hemodialysis Patients: Prevalence, Associated Factors, and the Influence of Nutritional Status. [PDF]

Nutrients
Casaux-Huertas A, Sánchez-Tocino ML, San Juan-Miguelsanz M, Audije-Gil J, Romero-Lugo N, Muñoz-Pilar S, Da Pena-Vielba F, Hernan-Gascueña D, Manso-Del Real P, Escribano-Loma S, Sánchez-Beato CC, Arenas-Jiménez MD, Research Unit Fundación Renal Española, Fragildial Working Group Fundación Renal Española.   +13 more
europepmc   +1 more source

Comparative Outcomes of Apixaban and Acenocoumarol in Advanced Chronic Kidney Disease and Atrial Fibrillation: A Retrospective Observational Study. [PDF]

J Clin Med
Suliman IL, Tuta LA, Panculescu FG, Alexandru A, Fasie D, Cimpineanu B, Cozaru GC, Popescu S, Enache FD, Manac I, Chisnoiu T, Alexandrescu L, Bordeianu I.   +12 more
europepmc   +1 more source

Therapeutic strategies for olfactory impairment in patients with chronic kidney disease: a systematic review. [PDF]

BMC Nephrol
Iravani K, Fereydoonnezhad T, Doostkam A, Malekmakan L.   +3 more
europepmc   +1 more source

Coronary Artery Bypass Surgery in Patients on Dialysis: In-Hospital Outcomes from UK Registry Analysis. [PDF]

Interdiscip Cardiovasc Thorac Surg
Mashat MA, Dong T, Kota R, Di Tommaso E, Narayan P, Tan C, Rajakaruna C, Mohamed Ahmed E, Angelini GD, Fudulu DP.   +9 more
europepmc   +1 more source

Clinical Factors Associated With Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease. [PDF]

Cureus
Fuchinoue Y, Sakaeyama Y, Matsuzaki R, Kubota S, Abe M, Terazono S, Nemoto M, Sugo N.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Renal Replacement II: Dialysis Dose

Critical Care Clinics, 2005
Improved survival of critically ill acute renal failure patients can be correlated with therapy dose. The overall solute elimination can be measured by the product of clearance and time (Kt), which is usually normalized for the volume of distribution (V) of the solute as "Kt/V." Setting a Kt/V threshold of 1.4 can guide clinicians toward adequate ...
Ricci Z, Ronco C
openaire   +3 more sources

Renal Dialysis and its Financing

Hospital Topics, 2016
The incidence of end-stage renal disease (ESRD) and its associated comorbidities such as diabetes and hypertension continue to increase as the population ages. As most ESRD patients qualify for Medicare coverage, the U.S. government initiated reforms of the payment system for dialysis facilities in an effort to decrease expenditures associated with ...
Marisa, Borelli, David P, Paul, Michaeline, Skiba   +2 more
openaire   +2 more sources

End-Stage Renal Disease—Dialysis

Psychiatric Clinics of North America, 1982
The child with end-stage renal disease is treated conservatively until symptoms prevent the child from attending school and other activities. At this point, a decision should be made to follow one of four courses: (1) hemodialysis, (2) peritoneal dialysis, (3) renal homotransplantation, or (4) allow the child to die. The choice of dialysis depends upon
openaire   +2 more sources